Latest Breaking News On - Pieris pharmaceuticals inc - Page 18 : comparemela.com

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

William blairInstitutional trading of pieris pharmaceuticalsOppenheimer coPieris pharmaceuticals incRaymond james associatesNews ratings for pieris pharmaceuticals dailyPieris pharmaceuticals stock performanceTower research capitalPieris pharmaceuticalsMirabella financial servicesFree reportGet free reportResearch capitalFinancial servicesTwo sigma investmentsPieris pharmaceuticals daily

Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews com

Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

William blairNews ratings for pieris pharmaceuticals dailyTower research capitalPieris pharmaceuticals stock performanceMirabella financial servicesHedge funds weigh in on pieris pharmaceuticalsPieris pharmaceuticals incPieris pharmaceuticalsTopco ltdHsbc holdingsOppenheimer coFree reportGet free reportFinancial servicesResearch capitalPieris pharmaceuticals daily

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews com

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

William blairPieris pharmaceuticals incPieris pharmaceuticalsRaymond james associatesOppenheimer coInstitutional investors weigh in on pieris pharmaceuticalsNews ratings for pieris pharmaceuticals dailyPieris pharmaceuticals stock performanceTower research capitalMirabella financial servicesFree reportGet free reportResearch capitalFinancial servicesTwo sigma investmentsPieris pharmaceuticals daily

Pieris Pharma Cuts Around 70% Workforce; Plans Strategic Options

Pieris Pharma Cuts Around 70% Workforce; Plans Strategic Options
nasdaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nasdaq.com Daily Mail and Mail on Sunday newspapers.

United kingdomStephen yoderPieris pharmaceuticals incMore such health newsNasdaq incNicolaus company inc

Pieris Pharmaceuticals : Provides Strategic Update and Announces Restructuring

Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring BOSTON,MA, July 18, 2023 - Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company.

United statesStephen yoderPieris pharmaceuticals provides strategicPieris pharmaceuticalsSecurities exchangeNicolaus company incExchange commissionPieris pharmaceuticals incCompany quarterly reports on formPieris pharmaceuticals provides strategic updateLooking statementsSecurities actSecurities exchange actAnnual reportQuarterly reports